Khasraw, M., Mukaro, V. R., West, L., White, K., Rippy, E., Brandt, C., … Patil, S. (2016). Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer. In Journal of Clinical Oncology (Vol. 34, pp. e12515–e12515). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.e12515

Khasraw, Mustafa, Violet Rudo Mukaro, Linda West, Karen White, Elisabeth Rippy, Conrad Brandt, Robert Tobler, et al. “Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.” In Journal of Clinical Oncology, 34:e12515–e12515. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e12515.

Khasraw M, Mukaro VR, West L, White K, Rippy E, Brandt C, et al. Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e12515–e12515.

Khasraw, Mustafa, et al. “Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. e12515–e12515. Crossref, doi:10.1200/jco.2016.34.15_suppl.e12515.

Khasraw M, Mukaro VR, West L, White K, Rippy E, Brandt C, Tobler R, Murphy CC, Collins IM, Baron-Hay SE, Ashley DM, Patil S. Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e12515–e12515.